These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32035733)

  • 1. Purification and in vivo stability and half-life of recombinant lipid modified staphylokinase.
    Mannully ST; Rekha VPB; Singh N; Shanthi C; Pulicherla KK
    Biologicals; 2020 Mar; 64():15-22. PubMed ID: 32035733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid modification of staphylokinase and its implications on stability and activity.
    Mannully ST; Shanthi C; Pulicherla KK
    Int J Biol Macromol; 2019 Jan; 121():1037-1045. PubMed ID: 30342946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression, purification and characterization of a novel staphylokinase with anti-platelet aggregation activity].
    Jingfang D; Jintian H; Ruiguang X; Xi C; Baohua Z
    Wei Sheng Wu Xue Bao; 2008 Sep; 48(9):1186-91. PubMed ID: 19062642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel recombinant thrombolytic and antithrombotic staphylokinase variants with an RGD motif at their N-termini.
    He J; Di J; Xu R; Zhao B
    Biotechnol Appl Biochem; 2008 May; 50(Pt 1):17-23. PubMed ID: 18039183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of site-specific PEGylation on the fibrinolytic activity, immunogenicity, and pharmacokinetics of staphylokinase.
    Liu J; Wang Z; He J; Wang G; Zhang R; Zhao B
    Acta Biochim Biophys Sin (Shanghai); 2014 Sep; 46(9):782-91. PubMed ID: 25098624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of a multifunctional staphylokinase variant with reduced reocclusion, produced from salt inducible E. coli GJ1158.
    Pulicherla KK; Kumar A; Gadupudi GS; Kotra SR; Rao KR
    Biomed Res Int; 2013; 2013():297305. PubMed ID: 23998121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel preparation protocol for the expression and purification of recombinant staphylokinase.
    Ren D; Li D; Yang W; Li Y; Gou X; Liang B; Li B; Wu Q
    Biotechnol Appl Biochem; 2008 Sep; 51(Pt 1):9-13. PubMed ID: 17967161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a multifunctional staphylokinase variant with thrombin inhibition and antiplatelet aggregation activities produced from salt-inducible E. coli GJ1158.
    Kumar A; Pulicherla KK; Mayuren C; Kotra S; Rao KR
    Can J Physiol Pharmacol; 2013 Oct; 91(10):839-47. PubMed ID: 24144055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale preparation of the delta10 form of staphylokinase by in vitro processing of recombinant staphylokinase with purified human plasminogen.
    Chattopadhyay D; Stewart JE; DeLucas LJ
    Appl Biochem Biotechnol; 1998 Mar; 69(3):147-56. PubMed ID: 9554081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous removal of T and B cell epitope in recombinant staphylokinase by structure-based mutagenesis of immuno-dominant Arg77 and Glu80 residues.
    Xu R; He J; Jia K; Chen X; Liu J; Zhu K
    Wei Sheng Wu Xue Bao; 2011 May; 51(5):692-703. PubMed ID: 21800633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation with Eight-Arm PEG Markedly Improves the In Vitro Activity and Prolongs the Blood Circulation of Staphylokinase.
    Qi F; Hu C; Yu W; Hu T
    Bioconjug Chem; 2018 Feb; 29(2):451-458. PubMed ID: 29298046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prokaryotic expression, purification and identification of recombinant staphylokinase-HC fusion protein].
    Chen J; Yang K; Guo Z; Zhang YL; Zhang SC; Yang W; Zhao SS; He Q; Wang DQ; Zhou JZ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1208-11. PubMed ID: 23127416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and characterization of a novel staphylokinase variant with thrombin-inhibitory activity.
    Wang M; Wang Y; Wang J; Zou M; Liu S; Xu T; Cai X; Wu C; Wang J; Xu D
    Biotechnol Lett; 2009 Dec; 31(12):1923-7. PubMed ID: 19685208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation of staphylokinase with the arabinogalactan-PEG conjugate: Study on the immunogenicity, in vitro bioactivity and pharmacokinetics.
    Qi F; Qi J; Hu C; Shen L; Yu W; Hu T
    Int J Biol Macromol; 2019 Jun; 131():896-904. PubMed ID: 30914374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an indirect competitive ELISA for quantification of recombinant staphylokinase in rabbit plasma: Application to pharmacokinetic study.
    Kumar A; Pulicherla KK; Sambasiva Rao KR
    J Immunoassay Immunochem; 2016; 37(3):228-42. PubMed ID: 26674740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High yielding recombinant Staphylokinase in bacterial expression system--cloning, expression, purification and activity studies.
    Mandi N; Soorapaneni S; Rewanwar S; Kotwal P; Prasad B; Mandal G; Padmanabhan S
    Protein Expr Purif; 2009 Mar; 64(1):69-75. PubMed ID: 19000928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous elimination of T- and B-cell epitope by structure-based mutagenesis of single Glu80 residue within recombinant staphylokinase.
    He J; Xu R; Chen X; Jia K; Zhou X; Zhu K
    Acta Biochim Biophys Sin (Shanghai); 2010 Mar; 42(3):209-15. PubMed ID: 20213046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel self-cleavage activity of Staphylokinase fusion proteins: An interesting finding and its possible applications.
    Prasad B; Salunkhe SS; Padmanabhan S
    Protein Expr Purif; 2010 Feb; 69(2):191-7. PubMed ID: 19638310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refolding of a staphylokinase variant y1-Sak by reverse dilution.
    He J; Wang G; Xu R; Feng J; Wang J; Su H; Song H
    Appl Biochem Biotechnol; 2008 Oct; 151(1):29-41. PubMed ID: 18785020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing a multifunctional staphylokinase variant (SAK-2RGD-TTI) with appropriate thrombolytic activity in vitro.
    Faraji H; Soltani F; Ramezani M; Sadeghnia HR; Nedaeinia R; Moghimi Benhangi H; Mashkani B
    Biotechnol Lett; 2020 Jan; 42(1):103-114. PubMed ID: 31686286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.